ABVX vs. INVA, LQDA, SAVA, MGNX, CNTA, PRTA, BLTE, IMNM, OPK, and MNKD
Should you be buying ABIVAX Société Anonyme stock or one of its competitors? The main competitors of ABIVAX Société Anonyme include Innoviva (INVA), Liquidia (LQDA), Cassava Sciences (SAVA), MacroGenics (MGNX), Centessa Pharmaceuticals (CNTA), Prothena (PRTA), Belite Bio (BLTE), Immunome (IMNM), OPKO Health (OPK), and MannKind (MNKD). These companies are all part of the "pharmaceutical preparations" industry.
Innoviva (NASDAQ:INVA) and ABIVAX Société Anonyme (NASDAQ:ABVX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, community ranking, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.
Innoviva has a net margin of 57.89% compared to Innoviva's net margin of 0.00%. ABIVAX Société Anonyme's return on equity of 30.37% beat Innoviva's return on equity.
99.1% of Innoviva shares are held by institutional investors. Comparatively, 47.9% of ABIVAX Société Anonyme shares are held by institutional investors. 1.4% of Innoviva shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Innoviva has higher revenue and earnings than ABIVAX Société Anonyme.
Innoviva received 291 more outperform votes than ABIVAX Société Anonyme when rated by MarketBeat users. However, 66.67% of users gave ABIVAX Société Anonyme an outperform vote while only 57.28% of users gave Innoviva an outperform vote.
ABIVAX Société Anonyme has a consensus target price of $32.00, suggesting a potential upside of 112.77%. Given Innoviva's higher possible upside, analysts clearly believe ABIVAX Société Anonyme is more favorable than Innoviva.
In the previous week, ABIVAX Société Anonyme had 7 more articles in the media than Innoviva. MarketBeat recorded 8 mentions for ABIVAX Société Anonyme and 1 mentions for Innoviva. ABIVAX Société Anonyme's average media sentiment score of 1.13 beat Innoviva's score of 0.82 indicating that Innoviva is being referred to more favorably in the media.
Summary
Innoviva beats ABIVAX Société Anonyme on 8 of the 12 factors compared between the two stocks.
Get ABIVAX Société Anonyme News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABVX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ABVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ABIVAX Société Anonyme Competitors List
Related Companies and Tools
